A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

NCT02203474 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
COPD

Interventions

DRUG: Tiotropium HFA BAI 5 mcg
DRUG: Tiotropium 18 mcg Capsule
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.